Latest News
Thanks to all the collaborators, clients, family, and friends who made 2024 such a success.
As we close another significant year, we celebrate remarkable achievements and expansions at ESQlabs. Moving forward into 2025, we are eager to deepen our impact on next-generation risk assessment, drive innovation in PBPK and QSP/QST modeling, and support the global shift toward reducing animal testing…
Empowering Global Health through Open-Source Modeling
A New joint Initiative to Advance Women’s Health and Tuberculosis Therapies in Regions with Constrained Healthcare Resources. This project, supported by funding from the Bill & Melinda Gates Foundation, centers on creating accessible, advanced modeling tools that …
Novel Liver Ring Trial Set to Revolutionize Drug Safety Assessment
Saterland, Germany, 28/05/2024 - In a first-of-its-kind initiative, TissUse (a leader in organ-on-chip technology) announced the commencement of the Liver Ring Trial. This collaborative effort involving ESQLabs (a computational model expert), UCB, a global...
ESQlabs business unit MPSlabs announces a Collaboration with Sanofi in Advancing Organ-on-Chip Technology
*Saterland, Germany, 17 of May, 2024* — esqLABS GmbH, a leading expert in modeling and simulation, announce a groundbreaking collaboration with Sanofi in Advancing Organ-on-Chip Technology through their business unit MPSlabs. This partnership aims to revolutionize...
Upcoming Events
ESQlabs at PAGE 2025
Click to download the posters our scientists are presenting at PAGE:HT-PBK Framework in R Using OSP Software for Anti-Tuberculosis Drug Development. Download Here. A PB-QSP Module for Ocular Applications for the Open Systems Pharmacology - A Vancomycin...
Meet us at SOT 2025!
Download our Posters here: ExpoAdvance Roadmap PosterValidation of PK Sim cat model for IV administrationAdvancing Maternal fetal and lactation PBK Models for Cross Species RA in Tox Meet us in Orlando! From March 16th to 20th this year, ESQlabs will be at the...
esqLABS will be at #FDA / #CERSI Pediatric Safety Workshop in Silver Spring (Feb 27-28, 2025)
Our CEO, Dr. Stephan Schaller, is an invited speaker for a joint CERSi FDA workshop on the topic of “Pediatric Developmental Safety Assessment: Novel Alternative Methods” next February …
News archive
ESQlabs as a major contributor to the advancement of OSPSuite with the Version 12 Update
ESQlabs is proud to have played a crucial role in the development of this big milestone: the updated version of OSP Suite! Together with the talented scientists and software developers from Bayer and Design2Code, our team has implemented the revolutionary...
Thanks to all the collaborators, clients, family, and friends who made 2024 such a success.
As we close another significant year, we celebrate remarkable achievements and expansions at ESQlabs. Moving forward into 2025, we are eager to deepen our impact on next-generation risk assessment, drive innovation in PBPK and QSP/QST modeling, and support the global shift toward reducing animal testing…
Empowering Global Health through Open-Source Modeling
A New joint Initiative to Advance Women’s Health and Tuberculosis Therapies in Regions with Constrained Healthcare Resources. This project, supported by funding from the Bill & Melinda Gates Foundation, centers on creating accessible, advanced modeling tools that …
Novel Liver Ring Trial Set to Revolutionize Drug Safety Assessment
Saterland, Germany, 28/05/2024 - In a first-of-its-kind initiative, TissUse (a leader in organ-on-chip technology) announced the commencement of the Liver Ring Trial. This collaborative effort involving ESQLabs (a computational model expert), UCB, a global...
ESQlabs business unit MPSlabs announces a Collaboration with Sanofi in Advancing Organ-on-Chip Technology
*Saterland, Germany, 17 of May, 2024* — esqLABS GmbH, a leading expert in modeling and simulation, announce a groundbreaking collaboration with Sanofi in Advancing Organ-on-Chip Technology through their business unit MPSlabs. This partnership aims to revolutionize...
ESQlabs Announces the Launch of MPSlabs as a Dedicated Business Unit
ESQlabs Announces the Launch of MPSlabs as a Dedicated Business Unit for leveraging modelling and simulation approaches for microphysiological systems. Saterland, Germany, 8th of May, 2024 — ESQlabs GmbH, a leader in biosimulation services and solutions, announces...
We Are Launching New Courses On OSP R & esqlabsR
Several online self-paced courses on OSP R package ecosystem & esqlabsR framework to help modelers streamline their PBPK models easier & faster are soon to be released live…
Deloitte Technology Fast 50 Award – 2023
For the 21st time: Deloitte honors the fastest growing tech companies in Germany. With impressive yearly revenue growth of 72.30 % ESQlabs ranks 30th on the Deloitte Technology Fast 50.
Happy New Year 2024!
Holidays may seem a long time ago, but it’s still a Happy New Year!
Thanks to all the collaborators, clients, family, and friends who made 2023 such a success.
Thanks to all the collaborators, clients, family, and friends who made 2023 such a success.
Organ-on-Chips and Digital Twins: The key to revolutionizing the drug development process
New Year
esqLABS is awarded £1.6M to develop a Virtual Second Species
esqLABS, led by Dr Stephan Schaller have been awarded £1.6M to deliver the CRACK IT Mega Challenge: Virtual Second Species, a project led by esqLABS Systems Toxicology Expert Dr Huan Yang…
March 7th, 2023, New organ-on-chip pilot seeks to reduce animal testing in consumer health industry
A groundbreaking pilot project has been launched to combine cutting-edge “organ-on-chip” (OoC) technology with a digital twin to study the blood-placenta-barrier in pregnant women…
January 9th, 2023, René Meyer joins esqLABS
René will support esqLABS in finance, HR, administration, and legal matters.
January 1st, 2023, Stella Fragki joins esqLABS
Stella will support esqLABS in toxicology and regulatory risk assessment.
2022 in Review for the esqLABS Team
2022 was a very productive year for the esqLABS team. After multiple conferences, training workshops, and new projects, we continued as motivated and committed as on our first day…
Deloitte Technology Fast 50 Award
For the 20th time: Deloitte honors the fastest growing tech companies in Germany. With a 4-year growth rate of 266.55 %, esqLABS GmbH got the 33th place.
OPEN POSITION: Business Development and Marketing Lead (m/f/d)
We are seeking a highly motivated Business Development Lead to extend our global reach through the effective and sustainable cultivation of new business opportunities and relationships.
September 12, 2022, Robert McIntosh joins esqLABS
Robert will help advance the OSP-Suite and thus contribute to the open-source movement.
(closed) OPEN POSITION(s): Senior R Developer (m/f/d)
To expand our team, esqLABS is seeking a Senior R Developer (Research Software Engineer for R (tools)) (f/m/d) to help us develop our R-based toolchain for the cutting-edge software “Open Systems Pharmacology Suite” within an …
August 1, 2022, Dr. Wilbert De Witte joins esqLABS
Wilbert will conduct projects as a principal consultant and share his expertise in PBK-modeling of large molecules.
July 1st, 2022, Sergei Vavilov joins esqLABS
Sergei will help develop the R package for the OSP-Suite.
January 1, 2022, René Geci joins esqLABS as external PhD
René Geci is a Systems Biologist who recently finished his master’s degree and now joins us as our first PhD student in collaboration with the RWTH Aachen (Germany) under…..
October 1, 2021, Dr. Alicia Paini joins esqLABS
Alicia will lead research programs on developing and applying physiologically based kinetic (PBK) models and developing strategies for new approach methodologies for chemical risk assessment…..
2021 in Review for the esqLABS Software Development Team
2021 was a busy year for the esqLABS software team, with lot of effort invested to deliver the new version 10 of the open-source modeling software “Open-Systems-Pharmacology Suite” (OSPSuite), …
2021 in Review for the esqLABS Team
In 2021, for our fourth year, esqLABS has again grown in numbers. After doubling our size in 2020, we were again able to grow our the esqLABS family by …
esqLABS provides training to US FDA Scientists on the use of the OSP Suite (PK-Sim® and MoBi®) for PBPK and QSP modeling and simulation
esqLABS has had the privilege to provide a detailed 3-day training to 15 Scientists from the U.S. Food and Drug Administration Division of Pharmacometrics, Office of Clinical Pharmacology …
September 1, 2021, Dr. Indrajeet Patil joins esqLABS
Indra is a physicist-turned-psychologist-turned-software developer passionate about applying his programming knowledge to build robust and user-friendly software applications….
July 1, 2021, Dr. Luis David Jimenez Franco joins esqLABS
Dr. Huan Yang is a mathematical modeler, who is passionate about computational modeling, data analysis, and machine learning for life-science innovation. Before joining esqLABS, Huan has applied systems modeling…
esqLABS joins EU project ONTOX
esqLABS is partnering with 17 institutions across the EU and the US to further develop computational approaches for next-generation risk assessment (NGRA) to provide a solution for advancing human risk assessment of chemicals without the use of animals…
May 1, 2021, Dr. Walter Schmitt joins esqLABS as Scientific Advisor
Walter Schmitt is an M&S scientist with more than 25 years of experience in the pharmaceutical and crop science industries. He will strengthen the esqLABS team of scientists with his deep knowledge in mechanistic and physiologically based modeling …
April 1, 2021, Dr. Huan Yang joins esqLABS
Dr. Huan Yang is a mathematical modeler, who is passionate about computational modeling, data analysis, and machine learning for life-science innovation. Before joining esqLABS, Huan has applied systems modeling…
OPEN POSITION: PhD Student QST (qAOP) (m/f/d)
We are seeking a highly talented and motivated PhD Student QST (qAOP) (m/f/d), keen on driving innovation and setting new boundaries in systems toxicology …
OPEN POSITION: Senior Scientist PBTK and QST (m/f/d)
We are seeking a highly talented and motivated Senior Scientist PBTK and QST (m/f/d), keen on driving innovation and setting new boundaries in systems toxicology …
2020 in Review for the OSP (PK-Sim & MoBi) Development Team
While the world seemed to stay still, this year was full of (e)motions for the Open Systems Pharmacology Community. esqLABS is thrilled to contribute to this initiative and witness its continued success …
2020 in Review for the esqLABS Team
What a year 2020! The esqLABS team has more than doubled in size and continues to grow: we now employ 8 great personalities from around the globe …
May 23, 2020, Dr. Abdel Rodriguez joins esqLABS
Dr. Abdel Rodríguez is a Computer Scientist with academic and industrial experience. He has balanced theory and practice experience in the field of Computer Science. He holds a MSc in Bioinformatics, a PhD in Machine Learning and more …
May 18, 2020, Dr. Frederico Severino Martins joins esqLABS
Dr. Frederico Martins is pharmacist with a PhD in Pharmaceutical Sciences from the University of São Paulo, Brazil. Prior to joining esqLABS, Dr. Martins worked as a pharmacometrics leader at Galapagos Pharmaceuticals in Paris …
May 1, 2020, Dr. Christian Maass joins esqLABS
Christian Maass is a physicist and computational biologist with over eight years of academic and industrial experience, where he established a strong national and international network. He is passionate about the integration …
May 1, 2020, Georgios Daskalakis joins esqLABS
Georgios Daskalakis is an experienced Software Developer with over 4 years of customer centric experience in software development in various fields. He started programming for BTC AG, contributing to the further …
OPEN POSITION: Scientific Director PBPK (m/f)
We are seeking a highly talented and motivated Scientific Director PBPK (m/f), keen on driving innovation and setting new boundaries in systems pharmacology …
esqLABS developing clinical decision support system
From within the „MoDiPro“ collaborations network, esqLABS & Partners have submitted a grant application for the GlucoSys Project. GlucoSys aims at developing a new technology solution for the control of blood glucose of intensive care patients in ICU wards…
June 22-26, 2018: esqLABS is @ ADA 78th Scientific Sessions
esqlabs will be @ American Diabetes Association’s 78th Scientific Sessions in Orlando, Florida. Reach out to us if you want to know how we can help you assess efficacy and outcome of novel Technology and Treatments in Diabetes using our PB-QSP Diabetes Platform....
May 31, 2018: esqLABS and Sanofi present @ PAGE 2018
esqLABS is presenting with Sanofi-Aventis Deutschland GmbH about their work to advance the translational capabilities of the PB-QSP Diabetes platform by supporting M&S for preclinical species…
May 31, 2018: esqLABS, Bayer and Saarland University present @ PAGE 2018
esqLABS is presenting with the Bayer AG and the Saarland University about their work to extend the compound database of the PB-QSP Diabetes platform by adding a PBPK module for GLP-1 and GIP…
esqLABS advancing OSPS
esqLABS is partnering with the Saarland University and the Bayer AG for the public-funding project OSMOSES to further develop the OPEN SOURCE software Open Systems Pharmacology Suite. The overall aim of the OSMOSES project is the further development of the “Open Systems…
January 1, 2018, Pavel Balazki joins esqLABS
Pavel is an interdisciplinary scientist with a solid experience in physiological modeling and programming skills. He focuses on the combination of modeling and software development to offer QSP platforms as integrated solutions…
November 29, 2017: esqLABS joins MoDiPro
„MoDiPro“ delivers innovative „Industry 4.0“ concepts for the Biotech and Health Care Industries. Within the collaborations network, partners from industry and academia work on joint R&D projects to develop smart devices and predictive computer (simulation-) models for digital decision support systems…
June 22, 2017: esqLABS is founded
esqLABS GmbH is founded as a German Limited Liability Company and registered with the register of commerce in Oldenburg, Germany.
Past events
ACoP 2024 (November 10th) Workshop 1: Biologics (ADC) whole-body PBPK/QSP
One day workshop on OSP Suite (PK-Sim®, MoBi®) on biologics (ADC) whole-body PBPK/QSP as part of the official program at the ACoP in Arizona, USA on November 10th…
PAGE 2024 (June 25th) Workshop 2: PBBM & Virtual Bioequivalence
One day workshop on OSP Suite (PK-Sim®, MoBi®) on physiologically based biopharmaceutics modeling (PBBM) and virtual bioequivalence at the PAGE Meeting in Rome, Italy on June 25th…
PAGE 2024 (June 24th) Workshop 1: Biologics & Small Molecule DDI
One day workshop on OSP Suite (PK-Sim®, MoBi®) on ADC & Small Molecule DDI at the PAGE Meeting in Rome, Italy on June 24th…
ASCPT 2024 (March 25th): 1-Day OSP-Suite Workshop & Webinar
esqLABS’ Team will be attending the ASCPT2024 in Colorado Springs, USA and shall be running a hybrid workshop demonstrating the application of PK-Sim® and MoBi® (OSP-Suite, www.open-systems-pharmacology.org) for use in physiologically-based pharmacokinetic (PBPK) and quantitative systems pharmacology (QSP) …
esqLABS will be at #SOT2024 in Salt Lake City (March 10-14)
esqLABS’ Team will be at the #SOT2024 in Salt Lake City from March 10 – 14 and proud to sponsor the Biological Modeling Specialty Section (BMSS) Welcome Reception! Look forward to seeing you there!
Get in touch now
Contact
ESQlabs GmbH | Am Sportplatz 7 | 26683 Saterland | Germany
Tel. +49 151 / 58559070 | info@esqLABS.com
This site does not use cookies to track your personal information